CSIMarket
 
Genetron Holdings Ltd  (GTH)
Other Ticker:  
 
    Sector  Healthcare    Industry Medical Laboratories
   Industry Medical Laboratories
   Sector  Healthcare
 
Price: $3.9000 $0.00 -0.128%
Day's High: $3.9 Week Perf: 0.00
Day's Low: $ 3.90 30 Day Perf: 2.63 %
Volume (M): 5 52 Wk High: $ 4.00
Volume (M$): $ 20 52 Wk Avg: $2.03
Open: $3.90 52 Wk Low: $0.69



 Market Capitalization (Millions $) -
 Shares Outstanding (Millions) -
 Employees 862
 Revenues (TTM) (Millions $) 94
 Net Income (TTM) (Millions $) -118
 Cash Flow (TTM) (Millions $) 93
 Capital Exp. (TTM) (Millions $) 10

Genetron Holdings Ltd
Genetron Holdings Ltd is a cutting-edge biotech company that develops and manufactures advanced gene testing and diagnostic solutions for cancer and other diseases. It was founded in 2015 and its headquarters are located in Beijing, China. Genetron Holdings Ltd is known for its innovative and advanced technology that enables it to provide reliable diagnostic and data analysis solutions to the medical industry.

Genetron's services and products have been widely used by hospitals, clinical labs, and research institutions across China and other countries. Its core business segments are cancer diagnosis and treatment, genetic screening and testing, and big data analysis. Its products are designed to help doctors and researchers better understand complex genetic and biological data to improve the accuracy of cancer diagnoses and provide personalized treatment plans for patients.

Using state-of-the-art technology, such as next-generation sequencing (NGS), Genetron's products are able to analyze cancer-related genes and genetic mutations with a high level of accuracy. The company's products also utilize artificial intelligence and machine learning algorithms to analyze large volumes of medical data quickly and accurately. This enables doctors to diagnose cancer at earlier stages, determine the most effective treatments, and monitor the efficacy of therapies.

Genetron Holdings Ltd has an experienced team of professionals, including biologists, bioinformatics experts, and data analysts who work together to advance its mission of advancing precision medicine for cancer and other diseases. The company has also established good relationships with major medical institutions and academic research centers across China and the world.

In conclusion, Genetron Holdings Ltd is a leader in the field of precision medicine and innovative technology that is transforming cancer diagnosis and treatment. Its focus on precision medicine is helping to revolutionize the way cancer is diagnosed and treated, leading to more accurate diagnoses, improved personalized treatment plans, and better outcomes for patients.


   Company Address: 1-2/F, Building 11, Zone 1 Beijing 102206
   Company Phone Number: 5090-7500   Stock Exchange / Ticker: NASDAQ GTH
   GTH is expected to report next financial results on May 11, 2024.


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
• View Complete Report
   



Merger and Acquisition

Genetron Health Announces Shareholders Approval of Merger Agreement.

Published Wed, Feb 21 2024 11:00 AM UTC

BEIJING, Feb. 21, 2024 - Genetron Holdings Limited (Genetron Health or the Company), a leading precision oncology platform company in China, has received shareholder approval for its proposed merger agreement. The decision was made at an extraordinary general meeting of shareholders held on February 21, 2024. The merger agreement, dated October 11, 2023, was authorized and a...






 

Genetron Holdings Ltd's Segments
 
 
• View Complete Report




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com